Prediction of Clinical Outcomes and Immunotherapy Response in Breast Cancer Based on T Cell-Mediated Tumor Killing-Related Traits
{{output}}
Introduction: Immune checkpoint inhibitors (ICIs) are becoming promising treatments for individuals with breast cancer (BRCA), yet only a limited number of patients show a favorable response to ICI therapy. Consequently, it is es... ...
